Sensus Healthcare (SRTS) Set to Announce Quarterly Earnings on Thursday

Sensus Healthcare (NASDAQ:SRTS) is set to announce its earnings results after the market closes on Thursday, November 14th. Analysts expect the company to announce earnings of ($0.02) per share for the quarter. Investors interested in listening to the company’s conference call can do so using this link.

Sensus Healthcare Trading Up 4.1 %

Shares of Sensus Healthcare stock opened at $7.05 on Tuesday. Sensus Healthcare has a twelve month low of $1.83 and a twelve month high of $7.18. The stock has a market capitalization of $115.55 million, a P/E ratio of 16.49 and a beta of 1.04. The business’s fifty day moving average price is $6.26 and its 200 day moving average price is $5.84.

Analyst Upgrades and Downgrades

Separately, HC Wainwright reiterated a “buy” rating and issued a $10.00 target price on shares of Sensus Healthcare in a report on Monday, August 12th.

Sensus Healthcare Company Profile

Sensus Healthcare, Inc, a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.